Trial Profile
Pilot Study on the Effect of Adalimumab on Vascular Inflammation in Patients With Moderate to Severe Plaque Psoriasis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs Adalimumab (Primary) ; Antipsoriatics
- Indications Plaque psoriasis
- Focus Pharmacodynamics
- 01 Aug 2011 Actual end date (Aug 2011) added as reported by ClinicalTrials.gov.
- 01 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 30 May 2011 Planned End Date changed from 1 Sep 2010 to 1 Jul 2011 as reported by ClinicalTrials.gov.